In the recent literature soft tissue neoplasms which harbor a recurrent YAP1::MAML2 fusion and have an epithelioid morphology with resemblance to myxoinflammatory fibroblastic sarcoma (MIFS) have been reported. In a recent series these tumors had a nodular appearance and central necrosis and were termed nodular necrotizing variants of MIFS. But their exact relationship to MIFS and their biological behavior seem to be unclear. We report a YAP1::MAML2 fusion positive nodular and necrotizing tumor with a MIFS-like morphology and provide a review of the literature.
PerretRTallegasMVelascoV, et al.Recurrent YAP1::MAML2 fusions in « nodular necrotizing » variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases. Mod Pathol. 2022;35:1398-1404.
2.
DermawanJKDiNapoliSESukhadiaP, et al.Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: a clinicopathologic study of seven cases demonstrating a heterogenous entity. Genes Chromosomes Cancer. 2023;62:191-201.
3.
LaskinWBFetschJFMiettinenM. Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome. Am J Surg Pathol. 2014;38:1-12.
4.
WHO Classification of Tumours Editorial Board. WHO Classification of Tumours of Soft Tissue and Bone. 5th ed. IARC Press; 2020.
5.
HallorKHSciotRStaafJ, et al.Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J Pathol. 2009;217:716-727.
6.
KaoYCRanucciVZhangL, et al.Recurrent BRAF gene rearrangements in myxoinflammatory fibroblastic sarcomas, but not hemosiderotic fibrolipomatous tumors. Am J Surg Pathol. 2017;41:1456-1465.
7.
SusterDMichalMHuangH, et al.Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases. Mod Pathol. 2020;33:2520-2533.
8.
AntonescuCRDicksonBCSungYS, et al.Recurrent YAP1 and MAML2 gene rearrangements in retiform and composite hemangioendothelioma. Am J Surg Pathol. 2020;44:1677-1684.
9.
ViveroMDavineniPNardiV, et al.Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions. Mod Pathol. 2020;33:560-565.
10.
SekineSKiyonoTRyoE, et al.Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. J Clin Invest. 2019;129:3827-3832.
11.
CordierFAmelootEDhoogeC, et al.Spindle cell/sclerosing rhabdomyosarcoma with a novel YAP1-MAML2 fusion in a 1-year-old: not all strongly TRK-expressing spindle cell sarcomas in infants are infantile fibrosarcomas. Pathol. 2021;53:936-939.
12.
PerretRMichalMCarrRA, et al.Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases. Histopathology. 2021;79:810-825.
13.
HuongGOlsonLCRippisGE, et al.An index case of cutaneous Hodgkin lymphoma and review of the literature. Am J Dermatopathol. 2016;38:739-743.
